Outbound Relationships |
Type |
Target |
Active |
Characteristic |
Refinability |
Group |
Values |
nalidixinsyre + natriumcitrat 660 mg brev brusegranulat |
Is a |
Product containing nalidixic acid (medicinal product) |
false |
Inferred relationship |
Some |
|
|
nalidixinsyre + natriumcitrat 660 mg brev brusegranulat |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Nalidixic acid (substance) |
false |
Inferred relationship |
Some |
|
|
nalidixinsyre + natriumcitrat 660 mg brev brusegranulat |
Is a |
nalidixinsyre + natriumcitrat |
false |
Inferred relationship |
Some |
|
|
nalidixinsyre + natriumcitrat 660 mg brev brusegranulat |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Disodium citrate (substance) |
false |
Inferred relationship |
Some |
|
|
nalidixinsyre + natriumcitrat 660 mg brev brusegranulat |
Has manufactured dose form |
Effervescent oral granules |
false |
Inferred relationship |
Some |
|
|
nalidixinsyre + natriumcitrat 660 mg brev brusegranulat |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Baktericid |
false |
Inferred relationship |
Some |
|
|
nalidixinsyre + natriumcitrat 660 mg brev brusegranulat |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Electrolyte |
false |
Inferred relationship |
Some |
|
|
nalidixinsyre + natriumcitrat 660 mg brev brusegranulat |
Is a |
Product manufactured as oral dose form (product) |
false |
Inferred relationship |
Some |
|
|